Novan Inc. (NOVN)
NASDAQ: NOVN
· Real-Time Price · USD
0.09
-0.04 (-28.12%)
At close: Jul 25, 2023, 8:00 PM
-28.12% (1D)
| Bid | 0.08 |
| Market Cap | 2.64M |
| Revenue (ttm) | 24.71M |
| Net Income (ttm) | 999K |
| EPS (ttm) | -0.84 |
| PE Ratio (ttm) | -0.11202380952380953 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.09 |
| Volume | 6,929,105 |
| Avg. Volume (20D) | 1,036,545 |
| Open | 0.14 |
| Previous Close | 0.13 |
| Day's Range | 0.08 - 0.14 |
| 52-Week Range | 0.08 - 3.33 |
| Beta | -0.04 |
About NOVN
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete'...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 21, 2016
Employees 90
Stock Exchange NASDAQ
Ticker Symbol NOVN
Website https://www.novan.com